Richard Kauffman on The Chinese Wuhan Virus Tests

He says the first tests used in Wuhan were based on a technique used to develop indicators for certain types of lung cancer. They are RT PCR, which is PCR on RNA sequences. An indicator is not a test, it is merely a data point which can be combined statistically with others to provide a whole set of tests which one hopes will be more or less effective in detecting some type of cancer.


At 10 minutes 16 seconds on the 80% false-positive rate, see Hannah Fry - How to Bend The Rules at 16 minutes 33 seconds


At 24 minutes 4 seconds, on exosomes and viruses, see How Viruses WorkBritt Glaunsinger on the Genomics of SARS-CoV2 and this, from 7 minutes 4 seconds:


See This Shows The Sort of People Behind Outbreaks of Viral BS. In particular, this video in which Wolfgang Wodarg mentions a test developed in Berlin that was 'fast-track' approved by the WHO.


According to this CDC Web Page on Rapid Molecular Assays:
Molecular assays available for detecting influenza virus infection include rapid molecular assays, Reverse Transcription-Polymerase Chain Reaction (RT-PCR), and other nucleic acid amplification tests. These tests can detect influenza viral RNA or nucleic acids in respiratory specimens with high sensitivity and high specificity. Notably, the detection of influenza viral RNA or nucleic acids by molecular assays does not necessarily indicate detection of viable virus or on-going influenza viral replication. Available FDA-cleared molecular assays are listed in Table 3.
The FDA has approved this LabCorp COVID-19 RT-PCR test for COVID-19-CoV2 : https://www.fda.gov/media/136151/download under a rapid-response emergency protocol called the Accelerated Emergency Use Authorisation:


Comments

Popular posts from this blog

Stefan Molyneux on Resource Based Economy

Nikola Tesla and the End of The World

Sabine Hossenfelder - Lost in Math